drugset / Trial / NCT00646126

Antimalarial Treatments for Clearing Low Density P. Falciparum and Its Impact on Malaria Transmission

NCT00646126

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The malaria parasite Plasmodium falciparum remains at sub-patent level throughout the dry season in areas of seasonal malaria transmission. Targeting this parasite reservoir before the transmission season could be a good strategy for malaria control. We are conducting a randomized double blind placebo controlled mass drug administration trial in eight village to clear the dry season low level parasitaemia with an ultimate aim of controlling malaria in eastern Sudan.

Timeline

Start
2005-08
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Artesunate Small molecule
Comparator pyrimethamine Small molecule
Comparator sulfadoxine Small molecule